"the lung" trang 8 - tải miễn phí từ tailieunhanh
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
8    56    0
Potential genetic modifiers for somatic EGFR mutation in lung cancer: A metaanalysis and literature review

Potential genetic modifiers for somatic EGFR mutation in lung cancer: A metaanalysis and literature review
17    184    0
Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion

Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
10    75    0
Clinical analysis of patients with skeletal metastasis of lung cancer

Clinical analysis of patients with skeletal metastasis of lung cancer
10    106    0
RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma

RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma
18    85    0
Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer

Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer
10    45    0
Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis

Syntenin overexpression in human lung cancer tissue and serum is associated with poor prognosis
9    78    0
Abscopal effect of radiation on multiple lung metastases of lung adenocarcinoma: A case report

Abscopal effect of radiation on multiple lung metastases of lung adenocarcinoma: A case report
5    56    0
Distinct signatures of lung cancer types: Aberrant mucin O-glycosylation and compromised immune response

Distinct signatures of lung cancer types: Aberrant mucin O-glycosylation and compromised immune response
20    44    0
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
9    69    0
Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations

Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations
7    84    0
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain

LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
15    95    0
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multiinstitutional research study

Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: A multiinstitutional research study
8    97    0
Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma

Overexpression of p53R2 is associated with poor prognosis in lung sarcomatoid carcinoma
7    39    1
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    54    1
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
6    63    1
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: A multicenter randomized controlled trial

Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: A multicenter randomized controlled trial
9    62    1
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database
10    66    1
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand
12    75    1
ALK-rearranged lung squamous cell carcinoma responding to alectinib: A case report and review of the literature

ALK-rearranged lung squamous cell carcinoma responding to alectinib: A case report and review of the literature
5    69    1